In vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived HCV core protein.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2004-12-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBRC.2004.10.012PMID 15522201
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unique Features of Hepatitis C Virus Capsid Formation Revealed by De Novo Cell-Free Assembly

  2004cited by this paper
• Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver.

  2004cited by this paper
• Biophysical characterization of hepatitis C virus core protein: implications for interactions within the virus and host

  2004cited by this paper
• The N-terminal half of the core protein of hepatitis C virus is sufficient for nucleocapsid formation.

  2004influential reference
• Hepatitis C Virus-Like Particle Budding: Role of the Core Protein and Importance of Its Asp111

  2003cited by this paper
• Structured HCV nucleocapsids composed of P21 core protein assemble primary in the nucleus of Pichia pastoris yeast.

  2003cited by this paper
• Ultrastructural evidences of HCV infection in hepatocytes of chronically HCV-infected patients.

  2003cited by this paper
• Phosphorylation of hepatitis C virus core protein by protein kinase A and protein kinase C.

  2002cited by this paper
• Processing of the Hepatitis C virus precursor protein expressed in the methylotrophic yeast Pichia pastoris.

  2002cited by this paper
• Conformational changes accompanying self-assembly of the hepatitis C virus core protein.

  2002cited by this paper
• In vitro self-assembled HCV core virus-like particles induce a strong antibody immune response in sheep.

  2002cited by this paper
• Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets

  2002cited by this paper
• Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362].

  2002cited by this paper
• The Core Protein of Hepatitis C Virus Is Imported into the Nucleus by Transport Receptor Kap123p but Inhibits Kap121p-dependent Nuclear Import of Yeast AP1-like Transcription Factor in Yeast Cells*

  2002cited by this paper
• The Domains Required to Direct Core Proteins of Hepatitis C Virus and GB Virus-B to Lipid Droplets Share Common Features with Plant Oleosin Proteins*

  2002cited by this paper
• Self-Assembly of Nucleocapsid-Like Particles from Recombinant Hepatitis C Virus Core Protein

  2001influential reference
• Biogenesis of hepatitis C virus envelope glycoproteins.

  2001cited by this paper
• Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique.

  2001influential reference
• In vitro models for hepatitis C.

  2001cited by this paper
• Characterization of the HCV core virus-like particles produced in the methylotrophic yeast Pichia pastoris.

  2001cited by this paper
• Assembly of truncated HCV core antigen into virus-like particles in Escherichia coli.

  2001cited by this paper
• Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients

  2001influential reference
• Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5' untranslated region of the viral genome.

  2000cited by this paper
• Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris.

  2000cited by this paper
• Hepatitis C Virus Core Protein Interacts with 14-3-3 Protein and Activates the Kinase Raf-1

  2000cited by this paper
• Specific in vitro association between the hepatitis C viral genome and core protein

  1999cited by this paper
• Interaction of Hepatitis C Virus Core Protein with Viral Sense RNA and Suppression of Its Translation

  1999cited by this paper
• Ultrastructural and immunocytochemical evidences of core-particle formation in the methylotrophic Pichia pastoris yeast when expressing HCV structural proteins (core-E1).

  1999cited by this paper
• The Native Form and Maturation Process of Hepatitis C Virus Core Protein

  1998cited by this paper
• An alternative for purification of low soluble recombinant hepatitis C virus core protein: Preparative two‐dimensional electrophoresis

  1998cited by this paper
• Self-association of the C-terminal domain of the hepatitis-C virus core protein.

  1998influential reference
• Regulated processing of hepatitis C virus core protein is linked to subcellular localization

  1997cited by this paper
• Analysis of hepatitis C virus core protein interaction domains.

  1997cited by this paper
• Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase.

  1996cited by this paper
• Homotypic interaction and multimerization of hepatitis C virus core protein.

  1996influential reference
• Biosynthesis and biochemical properties of the hepatitis C virus core protein

  1994cited by this paper
• Expression and identification of hepatitis C virus polyprotein cleavage products

  1993cited by this paper
• p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts.

  1992cited by this paper
• Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.

  1991cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development.

  2024cites this paper
• Yeast and Virus-like Particles: A Perfect or Imperfect Couple?

  2023cites this paper
• Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery

  2023cites this paper
• Genetically Engineered Hepatitis C Virus-like Particles (HCV-LPs) Tagged with SP94 Peptide to Acquire Selectivity to Liver Cancer Cells via Grp78

  2022cites this paper
• A simple method to purify recombinant HCV core protein expressed in Pichia pastoris for obtaining virus-like particles and producing monoclonal antibodies.

  2021cites this paper
• In Vitro Assembly of Virus-Like Particles and Their Applications

  2021cites this paper
• Biología molecular del virus de la hepatitis C

  2018cites this paper
• Production of Ebola virus-like particles in Drosophila melanogaster Schneider 2 cells

  2018cites this paper
• Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C

  2017cites this paper
• Yeast as an expression system for producing virus‐like particles: what factors do we need to consider?

  2017cites this paper
• Expression, Purification and Immunogenic Description of a Hepatitis C Virus Recombinant CoreE1E2 Protein Expressed by Yeast Pichia pastoris

  2015cites this paper
• The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection.

  2015cites this paper
• Different applications of virus‐like particles in biology and medicine: Vaccination and delivery systems

  2015cites this paper
• Recombinant Coree1e2 Protein Expressed in Pichia pastoris Yeast aCandidate Vaccine for Hepatitis C Virus

  2014cites this paper
• Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

  2013cites this paper
• Conformational and Thermal Stability Improvements for the Large-Scale Production of Yeast-Derived Rabbit Hemorrhagic Disease Virus-Like Particles as Multipurpose Vaccine

  2013cites this paper
• Hepatitis C virus--proteins, diagnosis, treatment and new approaches for vaccine development.

  2012cites this paper
• Mechanisms of Hepatitis C virus infection of human T lymphocytes

  2012cites this paper
• Of lives and livers: emerging responses to the hepatitis C virus.

  2011cites this paper
• Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK–ERK1/2 signaling events

  2010cites this paper
• Characterization of Hepatitis C Virus Core Protein Multimerization and Membrane Envelopment: Revelation of a Cascade of Core-Membrane Interactions

  2009cites this paper
• In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus

  2009cites this paper
• Baculovirus-expressed virus-like particles of Pea enation mosaic virus vary in size and encapsidate baculovirus mRNAs.

  2009cites this paper
• Human dendritic cells and hepatitis C Virus

  2009cites this paper
• New alternatives for the development of vaccine preparations : contributions to the knowledge on the interaction of recombinant protein viral antigens with nucleic acids

  2008cites this paper
• Purification of Bionanoparticles

  2008cites this paper
• Evidence for cellular uptake of recombinant hepatitis C virus non‐enveloped capsid‐like particles

  2007cites this paper
• Molecular virology of the hepatitis C virus: implication for novel therapies.

  2006cites this paper
• HSV-1 based amplicon vectors as an alternative system for the expression of functional HCV proteins.

  2006cites this paper
• HCV Genome and Life Cycle

  2006cites this paper
• Spectroscopic study of conformational changes accompanying self‐assembly of HCV core protein

  2006cites this paper
• Implications of the HCV subgenome discovery for viral pathogenesis, persistence and proliferation

  2006cites this paper
• Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus.

  2006cites this paper
• Hepatitis C virus (HCV) core protein enhances the immunogenicity of a co‐delivered DNA vaccine encoding HCV structural antigens in mice

  2006cites this paper
• Detection of HCV Components and Pathological Reactions in Apoptotic Hepatocytes from Chronically HCV-infected Patients

  2005cites this paper
• Molecular virology of the hepatitis C virus: implication for novel therapies.

  2005cites this paper
• Interaction of a C-terminal Truncated Hepatitis C Virus Core Protein with Plasmid DNA Vaccine Leads to in vitro Assembly of Heterogeneous Virus-like Particles

  2005cites this paper
• A C-terminal truncated hepatitis C virus core protein variant assembles in vitro into virus-like particles in the absence of structured nucleic acids.

  2005cites this paper
• The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.

  2005influential citation